18:48 , Feb 8, 2018 |  BC Extra  |  Company News

Management tracks: CRISPR, Arcturus

Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) said CSO Bill Lundberg is stepping down. He will become head of CRISPR's scientific advisory board. RNA therapeutics company Arcturus Therapeutics Ltd. (NASDAQ:ARCT) said President and CEO Joseph...
07:00 , Sep 24, 2012 |  BC Week In Review  |  Clinical News

VivaScope System diagnostic data

An analysis of 710 cutaneous lesions excised to exclude malignancy showed that Caliber's VivaScope System had 100% sensitivity and 88.5% specificity for detecting basal cell carcinoma (BCC). Additionally, VivaScope had 87.6% sensitivity and 70.8% specificity...